Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
68.8M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
29.2M
-
Shares change
-
+277K
-
Total reported value, excl. options
-
$230M
-
Value change
-
+$661K
-
Put/Call ratio
-
0.12
-
Number of buys
-
36
-
Number of sells
-
-30
-
Price
-
$7.87
Significant Holders of EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) as of Q2 2022
85 filings reported holding EYPT - EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.2M shares
of 68.8M outstanding shares and own 42.41% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (5.45M shares), Essex Woodlands Management, Inc. (4.19M shares), RA CAPITAL MANAGEMENT, L.P. (3.37M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.97M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.95M shares), BlackRock Inc. (1.57M shares), VANGUARD GROUP INC (1.36M shares), Point72 Asset Management, L.P. (1.22M shares), CITADEL ADVISORS LLC (1.04M shares), and GOLDMAN SACHS GROUP INC (888K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.